PP14
REAL-LIFE STUDY OF BIO-CLINICAL FOLLOW-UP AFTER BNT162b2 mRNA COVID-19 (BNTCV) VACCINATION IN 235 PATIENTS (PTS) INCLUDING 225 WITH HEMATOLOGICAL MALIGNANCIES (HM).
Jean-François Rossi1,2, Emmanuel Bonnet3, Marion Velensek1, Emma Wisniewski1, Sophie Heraud1, Rania Boustany1, Céleste David1, Jérôme Dinet4, Roland Sicard1, Jean-Pierre Daures3, Marion Bonifacy5, Lysiane Mousset5, Christel Castelli3, Emmanuel Goffart5
1 Institut du Cancer Avignon-Provence, Sainte Catherine, Avignon, France
2 Faculté de Médecine Montpellier, Université de Montpellier, Montpellier, France
3 Recherche Clinique Clinique Beau Soleil – Nouvelles Technologies, Montpellier, France
4 La Valériane Inc., 130 Rue de la Jasse de Maurin, 34070 Montpellier, France
5 Bioaxiome-Inovie, Laboratoire de Biologie Institut du Cancer Avignon-Provence, France
Read
1323
Timeswas read the article
601
Total PDF
722
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 16 | 8 | 24 |
| 2025 5 | 51 | 22 | 73 |
| 2025 4 | 41 | 13 | 54 |
| 2025 3 | 46 | 9 | 55 |
| 2025 2 | 41 | 22 | 63 |
| 2025 1 | 32 | 21 | 53 |
| 2024 12 | 26 | 30 | 56 |
| 2024 11 | 27 | 24 | 51 |
| 2024 10 | 35 | 26 | 61 |
| 2024 9 | 37 | 17 | 54 |
| 2024 8 | 32 | 24 | 56 |
| 2024 7 | 28 | 17 | 45 |
| 2024 6 | 39 | 21 | 60 |
| 2024 5 | 35 | 28 | 63 |
| 2024 4 | 28 | 19 | 47 |
| 2024 3 | 17 | 22 | 39 |
| 2024 2 | 22 | 25 | 47 |
| 2024 1 | 13 | 20 | 33 |
| 2023 12 | 18 | 16 | 34 |
| 2023 11 | 17 | 29 | 46 |
| 2023 10 | 8 | 14 | 22 |
| 2023 9 | 8 | 25 | 33 |
| 2023 8 | 11 | 12 | 23 |
| 2023 7 | 10 | 12 | 22 |
| 2023 6 | 19 | 22 | 41 |
| 2023 5 | 12 | 15 | 27 |
| 2023 4 | 6 | 8 | 14 |
| 2023 3 | 8 | 10 | 18 |
| 2023 2 | 7 | 11 | 18 |
| 2023 1 | 8 | 12 | 20 |
| 2022 12 | 10 | 20 | 30 |
| 2022 11 | 8 | 8 | 16 |
| 2022 10 | 6 | 19 | 25 |
Show all
